Freedom of Information request on information on whether the BPC or expert groups considered specific four articles (FOI 22/041)
Published 31 May 2022
FOI 22/041
31st January 2022
Dear
Thank you for your information request, dated 2nd November 2021, where you asked for Information on whether the BPC or expert groups considered four articles that you cited.
You have received the papers that the BPC and expert advisory groups received in response to your FOI request 21/852. These do not include the four articles cited.
The second article (numbered #2 in your list) was considered by the UK Delegation to the Ph. Eur. And was shared with EDQM in support of a revision request that the UK submitted back in 2010. This revision request was not accepted by the European Pharmacopoeia Commission.
If you have a query about the information provided, please reply to this email.
If you are unhappy with our decision, you may ask for it to be reviewed. That review will be undertaken by a senior member of the Agency who has not previously been involved in your request. If you wish to pursue that option please email: info@mhra.gov.uk
Due to the ongoing Covid-19 pandemic, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices.
After that, if you remain dissatisfied, you may write to the Information Commissioner at;
The Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
They will make a decision on whether or not we have interpreted the FOIA correctly in handling your request.
Yours sincerely
MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000